CVAC
Price
$2.92
Change
-$0.12 (-3.95%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
681.99M
43 days until earnings call
VIR
Price
$7.36
Change
-$0.60 (-7.54%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
1.09B
52 days until earnings call
Ad is loading...

CVAC vs VIR

Header iconCVAC vs VIR Comparison
Open Charts CVAC vs VIRBanner chart's image
CureVac
Price$2.92
Change-$0.12 (-3.95%)
Volume$7.98K
Capitalization681.99M
Vir Biotechnology
Price$7.36
Change-$0.60 (-7.54%)
Volume$31.19K
Capitalization1.09B
CVAC vs VIR Comparison Chart
Loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVAC vs. VIR commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVAC is a Hold and VIR is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (CVAC: $3.04 vs. VIR: $7.96)
Brand notoriety: CVAC and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVAC: 57% vs. VIR: 36%
Market capitalization -- CVAC: $681.99M vs. VIR: $1.09B
CVAC [@Biotechnology] is valued at $681.99M. VIR’s [@Biotechnology] market capitalization is $1.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVAC’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • CVAC’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, CVAC is a better buy in the long-term than VIR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVAC’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 4 bullish TA indicator(s).

  • CVAC’s TA Score: 4 bullish, 4 bearish.
  • VIR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CVAC is a better buy in the short-term than VIR.

Price Growth

CVAC (@Biotechnology) experienced а -1.94% price change this week, while VIR (@Biotechnology) price change was -5.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

CVAC is expected to report earnings on May 21, 2025.

VIR is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($1.09B) has a higher market cap than CVAC($682M). VIR YTD gains are higher at: 8.447 vs. CVAC (-10.850). CVAC has higher annual earnings (EBITDA): 166M vs. VIR (-562.68M). VIR has more cash in the bank: 914M vs. CVAC (555M). CVAC has less debt than VIR: CVAC (40.1M) vs VIR (113M). CVAC has higher revenues than VIR: CVAC (543M) vs VIR (62M).
CVACVIRCVAC / VIR
Capitalization682M1.09B62%
EBITDA166M-562.68M-30%
Gain YTD-10.8508.447-128%
P/E Ratio5.74N/A-
Revenue543M62M876%
Total Cash555M914M61%
Total Debt40.1M113M35%
TECHNICAL ANALYSIS
Technical Analysis
CVACVIR
RSI
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
87%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
78%
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
76%
View a ticker or compare two or three
Ad is loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFMVX24.060.30
+1.26%
Commerce MidCap Value
JSCAX15.820.16
+1.02%
JHancock Small Cap Value A
VPADX92.330.47
+0.51%
Vanguard Pacific Stock Index Admiral
HNDRX77.090.39
+0.51%
Horizon Defined Risk Investor
MTCKX40.530.16
+0.40%
MFS Technology R1

CVAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with BNTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then BNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
-5.00%
BNTX - CVAC
44%
Loosely correlated
-1.85%
MRNA - CVAC
43%
Loosely correlated
+3.82%
ARCT - CVAC
42%
Loosely correlated
-8.89%
MDGL - CVAC
42%
Loosely correlated
+0.80%
AXON - CVAC
39%
Loosely correlated
+5.43%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with SANA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-1.36%
SANA - VIR
62%
Loosely correlated
+1.18%
AXON - VIR
47%
Loosely correlated
+5.43%
GOSS - VIR
41%
Loosely correlated
-0.82%
AVIR - VIR
37%
Loosely correlated
-0.33%
CPRX - VIR
37%
Loosely correlated
+1.34%
More